Skip to main content

ADVERTISEMENT

Patent foramen ovale

Review
11/25/2015

Andr√©s M. Pineda, MD1;  Christos G. Mihos, DO1;  Sandeep Singla, MD1;  Orlando Santana, MD1;  John Rhodes III, MD2;  Robert J. Sommer, MD3;  Charanjit S. Rihal, MD4;  Nirat Beohar, MD1

Andr√©s M. Pineda, MD1;  Christos G. ...
The authors provide a comprehensive review of the current transcatheter management of the most common intracardiac defects encountered in the adult population.
The authors provide a comprehensive review of the current transcatheter management of the most common intracardiac defects encountered in the adult population.
The authors provide a...
11/25/2015
Journal of Invasive Cardiology
Clinical Images
02/27/2013

Thomas Pilgrim, MD, Bernhard Meier, MD, Ahmed A. Khattab, MD

Thomas Pilgrim, MD, Bernhard Meier, M...
This case should cause reconsideration of the current FDA restriction regarding indication for PFO closure to patients with a recurrent event despite medical treatment.
This case should cause reconsideration of the current FDA restriction regarding indication for PFO closure to patients with a recurrent event despite medical treatment.
This case should cause...
02/27/2013
Journal of Invasive Cardiology
Review
02/27/2013

Carlo R. Bartoli, PhD1, Kelly C. McCants, MD2, Emma J. Birks, MD2, Michael P. Flaherty, MD, PhD2, Mark S. Slaughter, MD3

Carlo R. Bartoli, PhD1, Kelly C. McCa...
Patent foramen ovale (PFO) may complicate left ventricular assist device (LVAD) therapy. In this case study, we report a 70-year-old male with a HeartMate II LVAD at increased risk for thromboembolic stroke secondary to a PFO with...
Patent foramen ovale (PFO) may complicate left ventricular assist device (LVAD) therapy. In this case study, we report a 70-year-old male with a HeartMate II LVAD at increased risk for thromboembolic stroke secondary to a PFO with...
Patent foramen ovale (PFO) may...
02/27/2013
Journal of Invasive Cardiology